The 2024 MLB trade deadline was a milder attempt by the New York Mets to build a championship caliber roster. Somehow, they took the Los Angeles Dodgers to Game 6 of the NLCS. Clutch play down the stretch and into October was the reason why, at moments, the Mets were able to push the mighty Dodgers against the ropes.
Some big parts of the team’s October run were acquired in the summer. Ryne Stanek stunk in the regular season but was trustworthy in the playoffs. Jesse Winker had big hits and a helmet smash that made him popular with the fans. Although Phil Maton sank in the end, he was unmatched in the regular season with the way he threw in relief.
A lesser and maybe even forgotten trade was the one which swapped a Mets prospect for Tyler Zuber. Zuber never pitched for the 2024 Mets, logging only 2 innings in a single game in 2025 and allowing a pair of runs. To land him, the Mets gave up a promising minor league reliever named Paul Gervase who, now with the Dodgers, has become an option out of their bullpen shuttling back and forth from the majors and minors.
The Dodgers won a Mets trade they weren’t even involved with
Gervase first went to the Tampa Bay Rays on July 30, 2024. 366 days later on July 31, 2025, he was packaged with current Mets minor leaguer Ben Rortvedt and another for Hunter Feduccia.
Pitching to a modest 4.32 ERA last season with the Rays and Dodgers, Gervase has been better this season with a 2.35 ERA in 7.2 innings of work. He has an obvious flaw, walking 5.9 batters per 9 innings. Coming alongside his 9.4 K/9 rate, the poor control is what has held him back most from sticking on anyone’s major league roster.
The Triple-A numbers are good this season, owning a 3.60 ERA and 12.6 K/9 rate. But again, the walk totals are terrifying at 6.5 BB/9. Caught serving up a few too many home runs as well, 4 in only 25 innings, Gervase has places to go (the major leagues) with a map (throw more strikes) but maybe a fatal flaw holding him back.
A 12th round pick by the Mets in 2022, he’s one of the two players taken with a positive MLB WAR. The other is Brandon Sproat. Each is worth a low 0.2 four years after first taken.
The Dodgers have used him more as an innings eater than anything else this year with 3 of his 4 outings including 2+ innings of work. Far from a finished product, his useful effectiveness should have him hanging around for a while. And if not, maybe the Dodgers continue the annual tradition of trading him at the deadline.
